S

Sarah Cannon Research Institute

Community-based oncology clinical research organization

IT Project Manager

IT Project ManagementPosted on Nov 13
Full-time

About the Job

Requirements

  • A bachelor's degree or equivalent experience.
  • At least 3 years of work experience in IT project management; experience in clinical research, pharmaceuticals, or healthcare is strongly preferred.
  • Demonstrated applied experience establishing and delivering complex projects.
  • Ability to navigate a highly matrixed organization effectively.
  • Strong written and oral communication and presentation skills, including the ability to listen, understand, persuade, encourage, motivate, and inspire.

Responsibilities

  • Participate in complex projects, often involving cross-functional teams and matrix partners, and leverage cross-functional expertise across the organization as appropriate.
  • Lead projects involving new product and service launches, application development, systems integration, operational efficiency improvements, process reengineering, and infrastructure upgrades and deployments.
  • Participate in financial forecasts and provide ongoing reconciliation of resources and related project expenditures.
  • Identify methods to enhance project management capabilities and processes.
  • Perform other duties as assigned.

Desired Qualifications

  • PMP certification or Lean Six Sigma certification.
  • Agile Project Management and Scrum certification.

About the Company

Sarah Cannon Research Institute

Community-based oncology clinical research organization

Sarah Cannon Research Institute (SCRI) is a global oncology research organization that conducts cancer clinical trials in community settings, partnering with pharmaceutical and biotech sponsors, physicians, and patients to develop new treatments. It works as an oncology-focused contract research organization (CRO) and centralized site management organization (SMO), running trials across more than 200 locations with roughly 1,500 research physicians, and applies technology such as its Accelero platform to personalized-medicine studies. Over more than 30 years it has completed more than 900 first-in-human trials across early- to late-phase research. What sets SCRI apart is this community-based model paired with early-phase depth, which has helped advance most new cancer therapies the FDA approved in the past decade. The goal is to accelerate oncology research from early trials to approval and bring advanced cancer treatments to patients.

Company size
1-10
Company stage
Not listed
Total funding
Not listed
Headquarters
Beach Haven, NJ
Founded
Not listed

Recently Posted Jobs

Explore more opportunities at Sarah Cannon Research Institute

See more jobs